A Randomized Controlled Study of Efficacy and Safety of Accelerated Versus Standard Hepatitis B Vaccination in Advanced Chronic Kidney Disease Patients

Jathurong Kittrakulrat,Kanitha Tiankanon,Stephen J. Kerr,Salin Wattanatorn,Suwasin Udomkarnjananun,Somkanya Tungsanga,Roongruedee Chaiteerakij,Kearkiat Praditpornsilpa,Somchai Eiam-Ong,Yingyos Avihingsanon,Khajohn Tiranathanagul,Jakapat Vanichanan,Natavudh Townamchai

DOI: https://doi.org/10.1016/j.ekir.2024.01.014

IF: 6.234

2024-01-18

Kidney International Reports

Abstract:Introduction Hepatitis B virus (HBV) vaccination is crucial for seronegative advanced chronic kidney disease (CKD) patients, for protection during dialysis while preparing for transplantation. A standard regimen for HBV vaccination requires 24 weeks to be completed. An accelerated HBV vaccination regimen completed within 8 weeks has shown early effective seroconversion in healthcare workers. However, data in advanced CKD patients are limited. Methods A randomized controlled trial was conducted in advanced CKD (eGFR<30 mL/min/1.73 m 2 ) and dialysis patients. The patients were randomly assigned to either a standard HBV vaccination regimen (Engerix B; 40 μg at 0, 4, 8, and 24 weeks) or an accelerated regimen (40 μg at 0, 1, 2, 8 weeks). The anti-HBs antibody were measured at 12, 28, and 52 weeks. Seroconversion were defined as anti-HBs ≥10 IU/L. Results At 12 weeks, among the intention-to-treat population of 133 participants (65 in the accelerated and 68 in the standard groups), the accelerated group demonstrated significantly higher rates of seroconversion (83.08% vs 63.24%, p=0.01). In the per-protocol analysis of 125 patients (62 in the standard and 63 in the accelerated groups), the accelerated group exhibited higher seroconversion rate compared with the standard group (85.71% vs. 69.35%, p=0.03). At 28 and 52 weeks, the seroconversion rates were similar between the two groups. Conclusions In patients with advanced CKD, the accelerated HBV vaccination regimen demonstrated a significantly higher seroconversion rate at 12 weeks of vaccination. This finding suggests that the accelerated regimen is an effective option to achieve rapid seroconversion before initiating hemodialysis or undergoing kidney transplantation.

urology & nephrology